ADVERTISEMENT
ADVERTISEMENT
Nabsys appoints Alka Chaubey as chief medical and genomics officer
Chaubey will lead scientific strategy and accelerate global adoption of electronic genome mapping technology.
-
Bhavana P - Mon, 06, Jul 2026
- 11:57 EDT
- 24
Alka Chaubey / Bionano Genomics
Rhode Island-based electronic genome mapping technology company Nabsys has appointed Indian-origin molecular genetics expert Alka Chaubey as its first chief medical and genomics officer, effective July 6, the company announced.
In her new role, Chaubey will lead the company's medical and scientific affairs strategy, strengthen collaborations with researchers and key opinion leaders, and support the broader application of Nabsys' electronic genome mapping (EGM) platform in genomics research.
The appointment comes as Nabsys expands the use of its OhmX electronic genome mapping platform, a research-use-only technology designed to identify structural variants in the genome that may not be detected through conventional genomic approaches.
Also read: American Eagle names Ravi Thanawala as next CFO
"We are extremely excited that Dr. Chaubey has joined Nabsys. Her expertise and experience will be invaluable to us as we reach a pivotal moment in the evolution of genome mapping,” said Barrett Bready, founder and chief executive officer of the company.
He said her experience in clinical assay development, laboratory adoption and regulatory compliance would help advance the company's efforts to make high-resolution structural variant analysis more accessible to researchers worldwide.
Chaubey said she looked forward to working with the company's global collaborators to expand access to electronic genome mapping and accelerate discoveries in structural variant analysis.
"As Nabsys's first Chief Medical and Genomics Officer, I look forward to working closely with the Nabsys team, customers, and collaborators from around the world to accelerate adoption of electronic genome mapping, unlock new biological insights, and expand access to structural variant analysis.”
Chaubey brings more than two decades of experience in molecular genetics, cytogenomics, molecular diagnostics and structural variant analysis. She most recently served as chief medical officer at Bionano Genomics, where she helped advance the adoption of optical genome mapping across research and clinical applications.
According to her LinkedIn profile, Chaubey earned her Ph.D. from Guru Nanak Dev University. She is board-certified in clinical cytogenetics and genomics and clinical molecular genetics and genomics by the American Board of Medical Genetics and Genomics and has authored or co-authored more than 100 scientific publications, abstracts and book chapters.
Discover more at New India Abroad.
Leave A Comment
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login